Renasant

RNST · NYSE · Financials · United States

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

ROE

4.7%

Profit CAGR (2y)

+11.9%

EPS (FY2025)

2.07

Net profit (FY2025)

$181.3M

Ask MarketChacha about RNST

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

PeriodNet profitEPSROE
FY2025$181.3M2.074.7%
FY2024$195.5M3.277.3%
FY2023$144.7M2.566.3%

Quarterly

PeriodNet profitEPS
2026Q2$87.1M0.94
2026Q1$88.2M0.94
2025Q3$59.8M0.63
2025Q2$1.0M0.01
2025Q1$41.5M0.65
2024Q3$72.5M1.18
2024Q2$38.8M0.69
2024Q1$39.4M0.70
2023Q3$41.8M0.74
2023Q2$28.6M0.51
2023Q1$46.1M0.82

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.